A.R.T. Advisors’s CorMedix CRMD Stock Holding History

A.R.T. Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,454	Closed	-$94K	–	746
2016 Q2	$94K	Buy	+9,454	New	+$144K	﹤0.01%	1213

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

A.R.T. Advisors's CRMD Position: Q3 2016 in Review

A.R.T. Advisors sold out of CorMedix (CRMD) in Q3 2016, closing a stake of 9,454 shares — an estimated $94K sold.

A.R.T. Advisors first reported a position in CRMD in Q2 2016 and held it in 1 quarter. The position peaked at $94K in Q2 2016. 39 funds tracked by Wall St. Rank hold CRMD as of Q3 2016.

A.R.T. Advisors reported no remaining CorMedix position as of Q3 2016 after selling out during the quarter.
A.R.T. Advisors sold 9,454 CorMedix shares in Q3 2016, an estimated $94K.
A.R.T. Advisors first reported a position in CorMedix in Q2 2016 and held it in 1 quarter.
A.R.T. Advisors's CorMedix position peaked at $94K in Q2 2016.
39 funds tracked by Wall St. Rank held CorMedix as of Q3 2016.

Based on A.R.T. Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.